Miro Viitala

Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors

Miro Viitala, Reetta Virtakoivu, Sina Tadayon et al. · Clinical Cancer Research · 2019 · 111 citations

Life Sciences, Immunology, Oncology +17

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion

Laura Lehtinen, Kirsi Ketola, Rami Mäkelä et al. · Oncotarget · 2012 · 107 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

A validated gene regulatory network and GWAS identifies early regulators of T cell–associated diseases

Mika Gustafsson, Danuta R. Gawel, Lars Alfredsson et al. · Science Translational Medicine · 2015 · 82 citations · Full text

Life Sciences, Genetics, Immunology +17

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial

Reetta Virtakoivu, Jenna H. Rannikko, Miro Viitala et al. · Clinical Cancer Research · 2021 · 53 citations · Full text

Life Sciences, Immunology, Oncology +17

Continuous Hypoxic Culturing of Human Embryonic Stem Cells Enhances SSEA-3 and MYC Levels

Elisa Närvä, Juha‐Pekka Pursiheimo, Asta Laiho et al. · PLoS ONE · 2013 · 50 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +15